Capdevila, J
Casanovas, O http://orcid.org/0000-0002-4298-3995
Salazar, R http://orcid.org/0000-0001-9419-6232
Castellano, D
Segura, A
Fuster, P
Aller, J
García-Carbonero, R
Jimenez-Fonseca, P
Grande, E
Castaño, J P
Article History
Received: 9 June 2016
Revised: 19 July 2016
Accepted: 22 July 2016
First Online: 19 September 2016
Competing interests
: JC: advisory, speaker role and investigational grants from Pfizer, Novartis and Ipsen. JPC: advisory, speaker fees and investigational grants from Novartis and Ipsen. AS: speaker role and investigational grants from Pfizer, Novartis and Ipsen. RS: advisory, speaker role from Novartis and Ipsen.
: The authors declare no conflict of interest.